[1] Long term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin or placebo

[2] Ribavirin for respiratory syncytial virus lower respiratory tract infection. A systematic overview

[3] Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease

[4] Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study

[5] Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection